Tuberculosis causes almost 3 million deaths per year worldwide. A vaccine effective against tuberculosis is essential to control or elimination of this disease. Great strides have been made in our understanding of the immune responses important in protection against this disease, and this knowledge is fundamental in the design of a vaccine. A non-human primate model for tuberculosis would provide answers to many questions about immune responses to M. tuberculosis as well as provide an animal model for testing vaccines and drugs. Results obtained in such a model may be relevant to human studies. Here we propose three specific aims: 1) establishment of a non-human primate model for tuberculosis; 2) assessment of immunologic correlates of tuberculosis in a non-human primate model; and 3) the effect of coinfection with M. tuberculosis and SIV on progression to AIDS, as well as reactivation of latent tuberculosis. Monkeys with tuberculosis can be quite infectious to humans and to monkeys. A primate Biosafety Level 3 facility will be outfitted so that appropriate and safe techniques are used in these studies. We will compare rhesus macaque and cynomolgus monkeys with respect to the ability to control a low dose (10 CFU, delivered to the lungs via bronchoscope) virulent M. tuberculosis infection, to determine whether a subset of animals of either species can control the infection in a chronic (or latent) state. Establishment of a non-human primate model for tuberculosis allows one to obtain tissue not generally available from human studies, including lung tissue and granulomas at various times post-infection. Monkeys in these studies will be used to study localized immune responses to tuberculosis, i.e. T cells, macrophages and cytokines in the pulmonary granulomas at various times post-infection, using a variety of techniques. The rhesus or cynomolgus monkey may provide an excellent model for studying tuberculosis, including protective immune responses, but also provides a model for studying the interaction of two important pathogens: M. tuberculosis and HIV. Understanding this interaction, including the immunologic responses that occur during co-infection is key to the eventual control of these diseases. We will co-infect monkeys with SIV and M. tuberculosis to determine the effect that tuberculosis, and the chronic immune stimulation that accompanies it, has on SIV infection and progression to AIDS. Various immune parameters of localized responses in the co-infected monkeys will also be tested. Once a non-human primate model for tuberculosis is established, it could be used to test vaccines, immunotherapy, and new treatment options for tuberculosis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI047485-01
Application #
6076304
Study Section
Special Emphasis Panel (ZHL1-CSR-Q (S2))
Program Officer
Ginsberg, Ann M
Project Start
1999-09-30
Project End
2004-08-31
Budget Start
1999-09-30
Budget End
2000-08-31
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Genetics
Type
Schools of Medicine
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Lin, Philana Ling; Myers, Amy; Smith, Le'Kneitah et al. (2010) Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model. Arthritis Rheum 62:340-50
Flynn, JoAnne L; Chan, John (2005) What's good for the host is good for the bug. Trends Microbiol 13:98-102
Flynn, JoAnne L (2004) Immunology of tuberculosis and implications in vaccine development. Tuberculosis (Edinb) 84:93-101
Marino, Simeone; Pawar, Santosh; Fuller, Craig L et al. (2004) Dendritic cell trafficking and antigen presentation in the human immune response to Mycobacterium tuberculosis. J Immunol 173:494-506
Fuller, Craig L; Flynn, JoAnne L; Reinhart, Todd A (2003) In situ study of abundant expression of proinflammatory chemokines and cytokines in pulmonary granulomas that develop in cynomolgus macaques experimentally infected with Mycobacterium tuberculosis. Infect Immun 71:7023-34
Capuano 3rd, Saverio V; Croix, Denise A; Pawar, Santosh et al. (2003) Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection. Infect Immun 71:5831-44
Tufariello, JoAnn M; Chan, John; Flynn, JoAnne L (2003) Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infect Dis 3:578-90
Flynn, JoAnne L; Chan, John (2003) Immune evasion by Mycobacterium tuberculosis: living with the enemy. Curr Opin Immunol 15:450-5
Flynn, J L; Capuano, S V; Croix, D et al. (2003) Non-human primates: a model for tuberculosis research. Tuberculosis (Edinb) 83:116-8
Algood, Holly M Scott; Chan, John; Flynn, JoAnne L (2003) Chemokines and tuberculosis. Cytokine Growth Factor Rev 14:467-77